The Duke National University of Singapore (Duke-NUS) is a Singapore-based institution of higher education. It offers doctor of medicine (MD), combination MD and doctor of philosophy (PhD), and PhD programs.
Duke-NUS partnered with Arcturus Therapeutics to develop a vaccine for COVID-19. The pair used STARR technology, which combines self-replicating RNA with LUNAR, a nanoparticle non-viral delivery system. The role of Duke-NUS was to isolate and cultivate the virus so that developments for a vaccine could commence.
Professor Thomas M. Coffman
Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR TechnologyTMCollaboration seeks to conduct pre-clinical testing followed by first-in-human clinical trials
March 4, 2020
Duke-NUS researchers at the front line of COVID-19 | NUS Research News
March 26, 2020
Documentaries, videos and podcasts
Duke-NUS Medical School
June 22, 2016
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.